Guoqing Wei

955 total citations
31 papers, 572 citations indexed

About

Guoqing Wei is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Guoqing Wei has authored 31 papers receiving a total of 572 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hematology, 11 papers in Oncology and 10 papers in Molecular Biology. Recurrent topics in Guoqing Wei's work include Multiple Myeloma Research and Treatments (10 papers), Acute Myeloid Leukemia Research (8 papers) and CAR-T cell therapy research (5 papers). Guoqing Wei is often cited by papers focused on Multiple Myeloma Research and Treatments (10 papers), Acute Myeloid Leukemia Research (8 papers) and CAR-T cell therapy research (5 papers). Guoqing Wei collaborates with scholars based in China, United States and South Korea. Guoqing Wei's co-authors include K. Arbter, G. Hirzinger, Zhen Cai, He Huang, He Huang, Yongxian Hu, Delong Liu, Wanmao Ni, Linghui Zhou and Qin Yu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Guoqing Wei

29 papers receiving 557 citations

Peers

Countries citing papers authored by Guoqing Wei

Since Specialization

Citations

This map shows the geographic impact of Guoqing Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guoqing Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guoqing Wei more than expected).

Fields of papers citing papers by Guoqing Wei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guoqing Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guoqing Wei. The network helps show where Guoqing Wei may publish in the future.

Co-authorship network of co-authors of Guoqing Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Guoqing Wei. A scholar is included among the top collaborators of Guoqing Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guoqing Wei. Guoqing Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prominent efficacy and good safety of sequential CD19 and CD22 CAR-T therapy in relapsed/refractory adult B-cell acute lymphoblastic leukemia 2025 ·Experimental Hematology and Oncology ·Tingting Yang, Yetian Dong, Mingming Zhang, Jingjing Feng, Shan Fu, (unknown), Ruimin Hong, Huijun Xu, Jiazhen Cui, (unknown), Guoqing Wei, Delin Kong, Jia Geng, Alex H. Chang, He Huang, Yongxian Hu	3
2	Safety and efficacy of autologous humanized CD19 CAR-T cell therapy for relapsed/refractory B-cell non-Hodgkin lymphoma 2025 ·Bone Marrow Transplantation ·(unknown), Tingting Yang, (unknown), (unknown), Rongrong Chen, (unknown), Ruimin Hong, Jingjing Feng, Shan Fu, (unknown), Huijun Xu, Jiazhen Cui, (unknown), Guoqing Wei, Alex H. Chang, He Huang, Yongxian Hu	1
3	Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients With Acute Myeloid Leukemia Harboring KMT2A Rearrangement and Its Prognostic Factors 2024 ·Cell Transplantation ·Bingqian Jiang, Yanmin Zhao, Yi Luo, Jian Yu, Yi Chen, Baodong Ye, Huarui Fu, Xiaoyu Lai, Lizhen Liu, Yishan Ye, Weiyan Zheng, Jie Sun, Jingsong He, Yi Zhao, Guoqing Wei, Zhen Cai, He Huang, Jimin Shi	4
4	Sequential CD19 and CD22 CAR-T Therapy in Relapsed/Refractory Acute Lymphoblastic Leukemia 2024 ·Blood ·Tingting Yang, Yetian Dong, Mingming Zhang, Jingjing Feng, Shan Fu, (unknown), Ruimin Hong, Huijun Xu, Jiazhen Cui, (unknown), Guoqing Wei, Alex H. Chang, (unknown), Yongxian Hu	1
5	A rare KMT2A::CBL transcript in an acute monoblastic leukemia patient with an unfavorable outcome 2024 ·Molecular Biology Reports ·Jinglei Yu, (unknown), Mingming Zhang, (unknown), Jingjing Feng, Ruimin Hong, Yongxian Hu, He Huang, Guoqing Wei	0
6	Different Patient Subgroup Different Maintenance, Proteasome Inhibitors or Immunomodulators Maintenance for Newly Diagnosed Multiple Myeloma: A 7-Year Single-Center Data in China 2021 ·Frontiers in Oncology ·Xiaoyan Han, (unknown), Gaofeng Zheng, Donghua He, Yi Zhao, Yi Li, Wenjun Wu, (unknown), Guoqing Wei, Enfan Zhang, He Huang, Jingsong He, Zhen Cai	0
7	Hemorrhage and venous thromboembolism in critically ill patients with COVID-19 2021 ·SHILAP Revista de lepidopterología ·Chenyang Qiu, Tong Li, Guoqing Wei, (unknown), (unknown), Ziheng Wu, Donglin Li, Yangyan He, Tianchi Chen, Jingchen Zhang, (unknown), Jia Hu, (unknown), Hongkun Zhang	7
8	Bortezomib-Based Regimens for Newly Diagnosed Multiple Myeloma in China: A Report of 12-Year Real-World Data 2020 ·Frontiers in Pharmacology ·Jingsong He, Donghua He, Xiaoyan Han, Gaofeng Zheng, Guoqing Wei, Yi Zhao, Yang Yang, Wenjun Wu, (unknown), (unknown), Hongwei Kong, He Huang, Zhen Cai	10
9	Different screening frequencies of carbapenem-resistant Enterobacteriaceae in patients undergoing hematopoietic stem cell transplantation: which one is better? 2020 ·Antimicrobial Resistance and Infection Control ·Tingting Yang, (unknown), Qing Yang, (unknown), Yi Luo, Yanmin Zhao, Yishan Ye, (unknown), Jian Yu, Yamin Tan, Guoqing Wei, He Huang, Jimin Shi	11
10	Calcineurin Inhibitors Replacement by Ruxolitinib as Graft-versus-Host Disease Prophylaxis for Patients after Allogeneic Stem Cell Transplantation 2020 ·Biology of Blood and Marrow Transplantation ·Yanmin Zhao, Jimin Shi, Yi Luo, Fei Gao, Yamin Tan, Xiaoyu Lai, Jian Yu, Guoqing Wei, He Huang	23
11	<p>Acute myeloid leukemia patient with <em>FLT3-ITD</em> and <em>NPM1</em> double mutation should undergo allogeneic hematopoietic stem cell transplantation in CR1 for better prognosis </p> 2019 ·Cancer Management and Research ·Yan Huang, Juan Hu, Ting Lu, Yi Luo, Jimin Shi, Wenjun Wu, Xiaoyan Han, Weiyan Zheng, Jingsong He, Zhen Cai, Guoqing Wei, He Huang, Jie Sun	14
12	Decitabine plus CLAG chemotherapy as a bridge to haploidentical transplantation in the setting of acute myeloid leukemia relapse after HLA-matched sibling transplantation: a case report 2019 ·BMC Cancer ·(unknown), Yongxian Hu, Wenjun Wu, Yi Luo, Yamin Tan, Jian Yu, Aiyun Jin, (unknown), He Huang, Guoqing Wei	3
13	" Internet-plus" practice focusing on medical service at tertiary general hospitals 2017 ·Zhonghua yiyuan guanli zazhi ·(unknown), Yunqing Qiu, Guoqing Wei, Min Zhou, Jun Zhou, (unknown)	1
14	Clinical implications of c-maf expression in plasma cells from patients with multiple myeloma 2017 ·Experimental Hematology and Oncology ·Guoqing Wei, Lijun Wang, Hanjin Yang, Xiaoyan Han, Gaofeng Zheng, Weiyan Zheng, Jie Sun, Jimin Shi, Wenjun Wu, Yi Zhao, Donghua He, Bo Wang, Zhen Cai, Jingsong He	4
15	The Choice of Regimens Based on Bortezomib for Patients with Newly Diagnosed Multiple Myeloma 2014 ·PLoS ONE ·Jingsong He, Li Yang, Xiaoyan Han, Gaofeng Zheng, Weiyan Zheng, Guoqing Wei, Wenjun Wu, Xiujin Ye, Jimin Shi, Wanzhuo Xie, Li Li, Jie Zhang, (unknown), Yi Zhao, He Huang, Xuejin Zhang, (unknown), Zhen Cai	13
16	Clinical Characteristics and Prognosis of Nonleukemic Myeloid Sarcoma 2013 ·The American Journal of the Medical Sciences ·Jingsong He, Xiujin Ye, Li Li, Jingjing Zhu, Jie Zhang, Wanzhuo Xie, Jimin Shi, Weiyan Zheng, Guoqing Wei, Jie Sun, Zhen Cai, He Huang, Lixia Zhu	12
17	Comparison of safety and toxicity of liposomal doxorubicin vs. conventional anthracyclines: a 2012 ·(unknown), Mohammed Fatih Rasul, Byung Moo Lee, Guoqing Wei, Gurpreet Lamba, Delong Liu	3
18	A meta-analysis of CAG (cytarabine, aclarubicin, G-CSF) regimen for the treatment of 1029 patients with acute myeloid leukemia and myelodysplastic syndrome 2011 ·Journal of Hematology & Oncology ·Guoqing Wei, Wanmao Ni, (unknown), Zhen Cai, He Huang, Delong Liu	72
19	Bortezomib in combination with dexamethasone and subsequent thalidomide for newly-diagnosed multiple myeloma: A Chinese experience 2009 ·Leukemia Research ·Weiyan Zheng, Guoqing Wei, Xiujin Ye, Jingsong He, Li Li, Wenjun Wu, Jimin Shi, Jie Zhang, (unknown), Wanzhuo Xie, Yi Luo, Xingkui Xue, Maofang Lin, He Huang, Zhen Cai	12
20	Self-guided robotic camera control for laparoscopic surgery compared with human camera control 1999 ·The American Journal of Surgery ·Kazuhiko Omote, Hubertus Feußner, A. Ungeheuer, K. Arbter, Guoqing Wei, J. R. Siewert, Gerd Hirzinger	78

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact